• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 60-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
AEK-9614316-5/1/1 24-May-2010 60LAY01 3003724366 GlaxoSmithKline Panama S.A. Panama
 
XXX-0173747-8/3/4 27-May-2010 60LBY05 3004117716 Quimica Franco Mexicana Nordin S.A. de C.V. Mexico
 
XXX-0173747-8/3/6 27-May-2010 60LBY05 3002895648 Bristol - Myers Squibb De Mexico, S. De R.L. De C.V. Mexico
 
XXX-0173747-8/3/3 27-May-2010 60LBY21 3008274551 Sanofi-Aventis De Mexico Mexico
 
AEK-8014313-0/4/1 18-May-2010 60LCA05 3008290618 Umar Mahmood Khan Pakistan
 
UPS-7977043-2/1/4 10-May-2010 60LDY01 3008287213 Oesterreichische Post Ag Austria
 
322-0244120-4/2/1/B 27-May-2010 60QAK07 3004855087 Aruba Aloe Balm N Aruba
 
112-6880510-2/1/1 24-May-2010 60QAR07 3005901829 Changzhou Sunchem Chemical Co Ltd China
 
224-2543949-8/12/1 17-May-2010 60QBY56 3005794644 New China Candy Co., Ltd. China
 
224-2543949-8/12/2 17-May-2010 60QBY56 3005794644 New China Candy Co., Ltd. China
 
AEK-9671482-5/1/1 06-May-2010 60SCA25 3006429103 Supermax Laboratories India
 
AEK-8014332-0/2/1 18-May-2010 60SCA25 3008290651 K.R. Sebastian India
 
XXX-0173732-0/2/6 10-May-2010 60SDY25 3005890938 Cinfa Spain
 
336-6103390-5/1/1 03-May-2010 60XDC17 3005719315 Watson Pharma Private Limited India
 
336-6103390-5/1/3 03-May-2010 60XDC17 3005719315 Watson Pharma Private Limited India
 
336-6103390-5/1/2 03-May-2010 60XDC17 3005719315 Watson Pharma Private Limited India
 
336-6103390-5/1/4 03-May-2010 60XDC17 3005719315 Watson Pharma Private Limited India
 
-
-